medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (5)


Review of the neurological manifestations of hepatitis E infection

Cheung MCM, Maguire J, Carey I, Wendon J, Agarwal K

Idioma: Ingles.
Referencias bibliográficas: 29
Paginas: 618-622
Archivo PDF: 79.25 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.

  2. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.

  3. Amarapurkar DN, Amarapurkar AD. Extrahepatic manifestations of viral hepatitis. Ann Hepatol 2002; 1: 192-5.

  4. Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, Rostaing L. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010; 10: 1321-4.

  5. Fourquet E, Mansuy JM, Bureau C, Recher C, Izopet J, Peron JM. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48: 73-4.

  6. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Masuy JM, Rostaing L, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173-9.

  7. Sood A, Midha V, Sood N. Guillain-Barre syndrome with acute hepatitis E. Am J Gastroenterol 2000; 95: 3667-8.

  8. Kamani P, Baijal R, Amarapurkar D, Gupte P, Patel N, Kumar P, Agal S. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol 2005; 24: 216.

  9. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 2011 [Epub].

  10. Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, et al. Guillain-Barre syndrome following hepatitis E. World J Gastroenterol 2009; 15: 1645-7.

  11. Cronin S, McNicholas R, Kavanagh E, Reid V, O’Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci 2011; 180: 255-7.

  12. Khanam RA, Faruq MO, Basunia RA, Ahsan ASM. Guillain-Barre syndrome associated with acute HEV hepatitis. Ibrahim Med Coll J 2008; 2: 32-4.

  13. Kumar R, Bhoi S, Kumar M, Sharma B, Singh BM, Gupta BB. Guillain-Barre syndrome and acute hepatitis E: a rare association. JIACM 2002; 3: 389-91.

  14. Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K. Hepatitis E-an unexpected problem at home. Scand J Gastroenterol 2012; 47: 253 [letter to editor].

  15. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009; 111: 193-5.

  16. Despierres LA, Kaphan E, Attarian S, Cohen-Bascrie S, Pelletier J, Pouget J, Motte A, et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis 2011; 17: 1510-2.

  17. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 2006; 43: 365-6.

  18. Tse ACT, Cheung RTF, Ho SL, Chan KH. Guillain-Barre syndrome associated with acute hepatitis E infection. J Clin Neurosci 2012; 19: 607-8.

  19. Inghilleri ML, Grini Mazouzi M, Juntas Morales R. Neuralgic amyotrophy as a manifestation of hepatitis E infection. Rev Neurol (Paris) 2012; 168: 383-4.

  20. Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scan J Infect Dis 2010; 42: 395-400.

  21. Yadav KK, Rohatgi A, Sharma SK, Kulshrestha M, Sachdeva S, Pardasani V. Oculomotor palsy associated with hepatitis E infection. J Assoc Physicians India 2002; 50: 737.

  22. Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001; 57: 1935.

  23. Thapa R, Mallick D, Biswas B. Psudotumor cerebri in childhood hepatitis E virus infection. Headache 2009; 49: 610-1.

  24. Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell’s palsy. J Assoc Physicians India 2006; 54: 418.

  25. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008; 7: 939-50.

  26. Haagsma EB, Riezebos-Brilman A, Van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16: 474-7.

  27. Kamar N, Rostaing L, Abravenel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, et al. Pegylated interferonalpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010: 50: e30-e33.

  28. Kusunoki S, Kaida K. Antibodies against ganglioside complexes in Guillain-Barre syndrome and related disorders. J Neurochem 2011; 116: 828-32.

  29. Van Alfen N. Clinical and patholophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol 2011; 7: 315-22.




2020     |     www.medigraphic.com